Literature DB >> 21334525

Paricalcitol for reduction of albuminuria in diabetes.

Alberto Ortiz, Maria Dolores Sanchez Niño, Jorge Rojas, Jesus Egido.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21334525     DOI： 10.1016/S0140-6736(11)60224-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease.

Authors:  Tina K Thethi; Muhammad A Bajwa; Husam Ghanim; Chanhee Jo; Monica Weir; Allison B Goldfine; Guillermo Umpierrez; Cyrus Desouza; Paresh Dandona; Ying Fang-Hollingsworth; Vasudevan Raghavan; Vivian A Fonseca
Journal:  J Diabetes Complications       Date:  2015-01-13       Impact factor: 2.852

2.  TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal Disease.

Authors:  Sandra Rayego-Mateos; Jose Luis Morgado-Pascual; José Manuel Valdivielso; Ana Belén Sanz; Enrique Bosch-Panadero; Raúl R Rodrigues-Díez; Jesús Egido; Alberto Ortiz; Emilio González-Parra; Marta Ruiz-Ortega
Journal:  J Am Soc Nephrol       Date:  2020-07-06       Impact factor: 10.121

Review 3.  Therapeutic approaches to diabetic nephropathy--beyond the RAS.

Authors:  Beatriz Fernandez-Fernandez; Alberto Ortiz; Carmen Gomez-Guerrero; Jesus Egido
Journal:  Nat Rev Nephrol       Date:  2014-05-06       Impact factor: 28.314

4.  A commentary on the VITAL study: Does vitamin D (receptor activation) protect against nephropathy in type 2 diabetes?

Authors:  Shinichi Okada; Kenichi Shikata
Journal:  J Diabetes Investig       Date:  2012-02-20       Impact factor: 4.232

5.  Effect of Vitamin D on Urinary Angiotensinogen Level in Early Diabetic Nephropathy.

Authors:  Himansu Sekhar Mahapatra; Adarsh Kumar; Bindu Kulshreshtha; Anubhuti Chitkara; Anamika Kumari
Journal:  Indian J Nephrol       Date:  2021-01-27

Review 6.  Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade.

Authors:  Maria Vanessa Perez-Gomez; Maria Dolores Sanchez-Niño; Ana Belen Sanz; Catalina Martín-Cleary; Marta Ruiz-Ortega; Jesus Egido; Juan F Navarro-González; Alberto Ortiz; Beatriz Fernandez-Fernandez
Journal:  J Clin Med       Date:  2015-06-18       Impact factor: 4.241

7.  Vitamin D deficiency and related risk factors in patients with diabetic nephropathy.

Authors:  Xiaoyan Xiao; Yajuan Wang; Yanlian Hou; Feng Han; Jianmin Ren; Zhao Hu
Journal:  J Int Med Res       Date:  2016-03-04       Impact factor: 1.671
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.